Impact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation.
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Fungemia in Hematologic Malignancies
- Status
- COMPLETED
- Phase
- N/A
Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)
- Status
- COMPLETED
- Phase
- PHASE2
Exercise in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
iCare for Cancer Patients
- Status
- TERMINATED
- Phase
- NA
Symbenda Post-Marketing Surveillance (PMS)
- Status
- COMPLETED
- Phase
- N/A
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Study of CWP232291 in Relapsed or Refractory Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Optimising Renal Outcome in Myeloma Renal Failure
- Status
- COMPLETED
- Phase
- PHASE2
Study of Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in HCT Recipients
- Status
- COMPLETED
- Phase
- PHASE2
"Monoclonal Antibodies for Treatment of Multiple Myeloma. Emphasis on the CD38 Antibody Daratumumab "
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
High Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Trial of VS-6766 Alone and in Combination With Everolimus
- Status
- COMPLETED
- Phase
- PHASE1
Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3